Literature DB >> 21913191

CFTR negatively regulates cyclooxygenase-2-PGE(2) positive feedback loop in inflammation.

Jing Chen1, Xiao Hua Jiang, Hui Chen, Jing Hui Guo, Lai Ling Tsang, Mei Kuen Yu, Wen Ming Xu, Hsiao Chang Chan.   

Abstract

Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-dependent anion channel mostly expressed in epithelia. Accumulating evidence suggests that CF airway epithelia are overwhelmed by excessive inflammatory cytokines and prostaglandins (PGs), which eventually lead to the over-inflammatory condition observed in CF lung disease. However, the exact underlying mechanism remains elusive. In this study, we observed increased cyclooxygenase-2 (COX-2) expression and over-production of prostaglandin E(2) (PGE(2)) in human CF bronchial epithelia cell line (CFBE41o--) with elevated NF-κB activity compared to a wild-type airway epithelial cell line (16HBE14o--). Moreover, we demonstrated that CFTR knockout mice had inherently higher levels of COX-2 and NF-κB activity, supporting the notion that lack of CFTR results in hyper-inflammatory signaling. In addition, we identified a positive feedback loop for production of PGE(2) involving PKA and transcription factor, CREB. More importantly, overexpression of wild-type CFTR significantly suppressed COX-2 expression in CFBE41o- cells, and wild-type CFTR protein expression was significantly increased when 16HBE14o-- cells were challenged with LPS as well as PGE(2), indicating possible involvement of CFTR in negative regulation of COX-2/PGE(2). In conclusion, CFTR is a negative regulator of PGE(2)-mediated inflammatory response, defect of which may result in excessive activation of NF-κB, leading to over production of PGE(2) as seen in inflammatory CF tissues.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21913191     DOI: 10.1002/jcp.23020

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  13 in total

1.  CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Authors:  B L N Than; J F Linnekamp; T K Starr; D A Largaespada; A Rod; Y Zhang; V Bruner; J Abrahante; A Schumann; T Luczak; A Niemczyk; M G O'Sullivan; J P Medema; R J A Fijneman; G A Meijer; E Van den Broek; C A Hodges; P M Scott; L Vermeulen; R T Cormier
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

Review 2.  Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.

Authors:  Xiaoqing Guan; Yuning Hou; Fei Sun; Zhe Yang; Chunying Li
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 3.  Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer.

Authors:  Jieting Zhang; Yan Wang; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Cell Mol Life Sci       Date:  2018-02-06       Impact factor: 9.261

4.  Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation.

Authors:  Ping-Xia Zhang; Jijun Cheng; Siying Zou; Anthony D D'Souza; Jonathan L Koff; Jun Lu; Patty J Lee; Diane S Krause; Marie E Egan; Emanuela M Bruscia
Journal:  Nat Commun       Date:  2015-02-10       Impact factor: 14.919

5.  CFTR-regulated MAPK/NF-κB signaling in pulmonary inflammation in thermal inhalation injury.

Authors:  Zhi Wei Dong; Jing Chen; Ye Chun Ruan; Tao Zhou; Yu Chen; YaJie Chen; Lai Ling Tsang; Hsiao Chang Chan; Yi Zhi Peng
Journal:  Sci Rep       Date:  2015-10-30       Impact factor: 4.379

6.  Impaired PGE2-stimulated Cl- and HCO3- secretion contributes to cystic fibrosis airway disease.

Authors:  Zachary M Sellers; Beate Illek; Miriam Frankenthal Figueira; Gopika Hari; Nam Soo Joo; Eric Sibley; Jackson Souza-Menezes; Marcelo M Morales; Horst Fischer; Jeffrey J Wine
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

7.  Defective CFTR- β-catenin interaction promotes NF-κB nuclear translocation and intestinal inflammation in cystic fibrosis.

Authors:  Kaisheng Liu; Xiaohu Zhang; Jie Ting Zhang; Lai Ling Tsang; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Oncotarget       Date:  2016-09-27

8.  NF κB expression increases and CFTR and MUC1 expression decreases in the endometrium of infertile patients with hydrosalpinx: a comparative study.

Authors:  Yong Song; Qiushi Wang; Wei Huang; Li Xiao; Licong Shen; Wenming Xu
Journal:  Reprod Biol Endocrinol       Date:  2012-10-15       Impact factor: 5.211

Review 9.  Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.

Authors:  Adam C Seegmiller
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

10.  Upregulation of CFTR in patients with endometriosis and its involvement in NFκB-uPAR dependent cell migration.

Authors:  Wenqing Huang; Aihong Jin; Jieting Zhang; Chaoqun Wang; Lai Ling Tsang; Zhiming Cai; Xiaping Zhou; Hao Chen; Hsiao Chang Chan
Journal:  Oncotarget       Date:  2017-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.